DEF 14AThe Ballot
NRX Pharmaceuticals, Inc. files DEF 14A
Filed Jan 10, 2023 · 3y ago · Accession 0001104659-23-002816
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- NRX Pharmaceuticals, Inc.
- Ticker
- NRXP
- CIK
- 1719406
- Form type
- DEF 14A
- Filing date
- Jan 10, 2023
- Report date
- Feb 2, 2023
- Document
- tm2233294-2_def14a.htm
- Size
- 1.7 MB